Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tesla Motors (TSLA) down 4% after Apple (AAPL) deal speculation

Stockhouse Editorial
0 Comments| February 19, 2014

{{labelSign}}  Favorites
{{errorMessage}}

The following is an excerpt from Canaccord Genuity’s Morning Coffee newsletter.

Shares of Tesla Motors Inc. (NASDAQ: TSLA, Stock Forum) got a lift (Monday) after the San Francisco Chronicle reported that Apple Inc. (NASDAQ: AAPL, Stock Forum) M&A chief, Adrian Percia, met with Tesla CEO Elon Mussk last spring, according to an unnamed source.

Details of the conversation are not known, but Apple could be looking at a partnership, product placement or buyout scenario. The tone of the analysts who commented on the story indicated that a partnership is more likely than a takeout. Tesla’s Model S sedan sports, a large touch screen on its dashboard.

Apple could provide content, or an interface for the system in a partnership scenario. Outside of Tesla, the article noted that Apple has established an interest in heart-related medical devices.

It has recently enhanced its health care expertise, hiring doctors and lawyers with experience lobbying the FDA.

After hitting an all-time high of $206 on Monday, Tesla shares were down 4% to $195.30 in early afternoon trading Tuesday, leaving the company with a market cap of $23.9 billion, based on 122.6 million shares outstanding. The 52-week range is $206 and $33.80.


{{labelSign}}  Favorites
{{errorMessage}}

Featured Company